Week Ending September 7, 2021

Yale Cancer Center Study Shows Stem-Like T Cells Could Aid Immunotherapy in Cancer Treatment
“In a new study by Yale Cancer Center, researchers show stem-like T cells within certain lymph nodes could be natural cancer fighters. Targeting these T cells, which are a type of white blood cells, with immunotherapy drugs could increase the number of cancer patients that respond to treatment. The findings were reported online today in the journal Science Immunology.”

Researcher receives $2.5 million grant to develop lung cancer treatment
“Newswise — A researcher at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center received a five-year, $2.5 million grant from the National Cancer Institute to develop a novel therapy to treat lung cancer.”

Cancer burden in West Virginia among highest in nation; advocates see solutions
“CLARKSBURG, W.Va. (WV News) — West Virginia has one of the highest rates of new cancer, as well as one of the highest cancer mortality rates in the nation.”

Hospital staff: Don’t let COVID-19 stop you from getting preventive care
“Nurse Christine Harrington said people don’t understand the importance of a colonoscopy or a mammogram, but she wasn’t sure how to verbalize how important this type of care is.”

VATS Better Than Open Lobectomy for Early-Stage Lung Cancer
“Video-assisted thoracoscopic surgery (VATS) for patients with early-stage non-small cell lung cancer (NSCLC) was associated with less pain, less cost, significantly lower complications and a shorter length of stay than open lobectomy in the randomized VIOLET study.”

Sintilimab Plus Chemo Prolongs Survival in Advanced Non-Small Cell Lung Cancer
“Updated results from the ORIENT-11 trial showed that adding sintilimab to chemotherapy significantly prolongs overall survival (OS) in patients with previously untreated, advanced nonsquamous non-small cell lung cancer (NSCLC). These results were published in the Journal of Thoracic Oncology.”

National Cancer Institute renews Simmons Cancer Center’s prestigious comprehensive designation
“DALLAS – Sept. 2, 2021 – The National Cancer Institute has renewed the Harold C. Simmons Comprehensive Cancer Center’s comprehensive designation, reaffirming its place among the country’s elite cancer institutes.”